0001875067-24-000001.txt : 20240209 0001875067-24-000001.hdr.sgml : 20240209 20240209161146 ACCESSION NUMBER: 0001875067-24-000001 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043404176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-34620 FILM NUMBER: 24615009 BUSINESS ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: John Minardo CENTRAL INDEX KEY: 0001875067 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 100 SUMMER STREET STREET 2: SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 144 1 primary_doc.xml 144 0001875067 XXXXXXXX LIVE 0001446847 IRONWOOD PHARMACEUTICALS INC 001-34620 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722 John Minardo Officer Class A Common Stock E Trade Securities LLC

3 Edison Drive Alpharetta GA 30005

55429 825892.10 156129046 02/12/2024 Nasdaq Class A Common Stock 08/02/2021 Performance-based Restricted Stock Unit award granted pursuant to Issuer's 2019 Equity Incentive Plan, subject to vesting requirements Ironwood Pharmaceuticals, Inc. N 79981 08/02/2021 N/A Class A Common Stock 03/02/2022 Restricted Stock Unit award granted pursuant to Issuer's 2019 Equity Incentive Plan, subject to vesting requirements Ironwood Pharmaceuticals, Inc. N 16968 03/02/2022 N/A Class A Common Stock 03/08/2023 Restricted Stock Unit award granted pursuant to Issuer's 2019 Equity Incentive Plan, subject to vesting requirements Ironwood Pharmaceuticals, Inc. N 16377 03/08/2023 N/A Y Shares sold to cover taxes from the vesting of stock awards granted by the Issuer. 02/09/2024 /s/ John Minardo